Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT05601596

Research OutSmarts Endometriosis II Study

Sponsor: Northwell Health

View on ClinicalTrials.gov

Summary

This product will be used as a diagnostic test to screen for the likelihood of endometriosis in menstruating adults with symptoms suggestive of endometriosis. The purpose of the test will be to guide clinical decisions regarding: 1) whether to undergo diagnostic laparoscopy to confirm the presence of endometriosis (currently, the gold standard for diagnosing endometriosis) and/or 2) how to guide the choice of hormonal or other therapies to treat symptoms of endometriosis.

Official title: ROSE II: Pilot Study to Analyze Menstrual Blood to Predict Endometriosis

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

OBSERVATIONAL

Enrollment

185

Start Date

2022-05-27

Completion Date

2025-06-01

Last Updated

2025-03-13

Healthy Volunteers

Yes

Conditions

Interventions

DIAGNOSTIC_TEST

Analysis of menstrual blood to predict endometriosis

Menstrual blood from controls and symptomatic cases will be analyzed using single cell RNA-sequencing to develop a panel of biomarkers that can be developed into a screening test or diagnostic test for endometriosis.

Locations (1)

Feinstein Institutes/Northwell health

Manhasset, New York, United States